183 related articles for article (PubMed ID: 22968185)
61. Outcomes of unresected ground-glass nodules with cytology suspicious for adenocarcinoma.
Gulati CM; Schreiner AM; Libby DM; Port JL; Altorki NK; Gelbman BD
J Thorac Oncol; 2014 May; 9(5):685-91. PubMed ID: 24722156
[TBL] [Abstract][Full Text] [Related]
62. Intravascular Large B-cell Lymphoma Presenting as Pulmonary Ground-glass Nodules That Progressed Slowly over Several Months with No Overt Symptoms.
Yamamoto R; Okagaki N; Sakamoto H; Tanaka Y; Takeda A; Maruguchi N; Nakamura S; Matsumura K; Ueyama M; Ikegami N; Kaji Y; Hashimoto S; Tanaka E; Taguchi Y; Maruyama W; Katsuragawa H; Sumiyoshi S; Hajiro T
Intern Med; 2024 Feb; 63(4):559-563. PubMed ID: 37407462
[TBL] [Abstract][Full Text] [Related]
63. Guidelines for the Investigation and Management of Ground Glass Nodules.
Lee JH; Hong JI; Kim HK
J Chest Surg; 2021 Oct; 54(5):333-337. PubMed ID: 34465667
[TBL] [Abstract][Full Text] [Related]
64. Characteristics of Ground-Glass Nodules Detected by Low-Dose Computed Tomography as a Regular Health Examination Among Chinese Hospital Employees and Their Parents.
Ouyang B; Li M; Li L; Liu S; Li M
Front Oncol; 2021; 11():661067. PubMed ID: 33987096
[TBL] [Abstract][Full Text] [Related]
65. Effect of lung volume and gravity on the attenuation and size of a pure ground-glass nodule.
Ferretti GR; Arbib F; Roux JF; Bland V; Lantuejoul S
J Thorac Imaging; 2012 Jan; 27(1):W15-7. PubMed ID: 21436745
[TBL] [Abstract][Full Text] [Related]
66. Long-term outcomes of 50 cases of limited-resection trial for pulmonary ground-glass opacity nodules.
Nakao M; Yoshida J; Goto K; Ishii G; Kawase A; Aokage K; Hishida T; Nishimura M; Nagai K
J Thorac Oncol; 2012 Oct; 7(10):1563-6. PubMed ID: 22878750
[TBL] [Abstract][Full Text] [Related]
67. How long should small lung lesions of ground-glass opacity be followed?
Kobayashi Y; Fukui T; Ito S; Usami N; Hatooka S; Yatabe Y; Mitsudomi T
J Thorac Oncol; 2013 Mar; 8(3):309-14. PubMed ID: 23399958
[TBL] [Abstract][Full Text] [Related]
68. Pure ground-glass opacity neoplastic lung nodules: histopathology, imaging, and management.
Lee HY; Choi YL; Lee KS; Han J; Zo JI; Shim YM; Moon JW
AJR Am J Roentgenol; 2014 Mar; 202(3):W224-33. PubMed ID: 24555618
[TBL] [Abstract][Full Text] [Related]
69. Visceral pleural invasion in lung adenocarcinoma ≤3 cm with ground-glass opacity: a clinical, pathological and radiological study.
Zhao LL; Xie HK; Zhang LP; Zha JY; Zhou FY; Jiang GN; Chen C
J Thorac Dis; 2016 Jul; 8(7):1788-97. PubMed ID: 27499970
[TBL] [Abstract][Full Text] [Related]
70. Incidental detection of ground glass nodules and primary lung cancer in patients with breast cancer: prevalence and long-term follow-up on chest computed tomography.
Ryu HS; Lee HN; Kim JI; Ryu JK; Lim YJ
J Thorac Dis; 2024 Mar; 16(3):1804-1814. PubMed ID: 38617779
[TBL] [Abstract][Full Text] [Related]
71. Using the CT features to differentiate invasive pulmonary adenocarcinoma from pre-invasive lesion appearing as pure or mixed ground-glass nodules.
Liang J; Xu XQ; Xu H; Yuan M; Zhang W; Shi ZF; Yu TF
Br J Radiol; 2015 Sep; 88(1053):20140811. PubMed ID: 26090823
[TBL] [Abstract][Full Text] [Related]
72. Natural History of Persistent Pulmonary Subsolid Nodules: Long-Term Observation of Different Interval Growth.
Tang EK; Chen CS; Wu CC; Wu MT; Yang TL; Liang HL; Hsu HT; Wu FZ
Heart Lung Circ; 2019 Nov; 28(11):1747-1754. PubMed ID: 30268516
[TBL] [Abstract][Full Text] [Related]
73. Evaluate the performance of four artificial intelligence-aided diagnostic systems in identifying and measuring four types of pulmonary nodules.
Wu MY; Li Y; Fu BJ; Wang GS; Chu ZG; Deng D
J Appl Clin Med Phys; 2021 Jan; 22(1):318-326. PubMed ID: 33369008
[TBL] [Abstract][Full Text] [Related]
74. Features of resolving and nonresolving indeterminate pulmonary nodules at follow-up CT: the NELSON study.
Zhao YR; Heuvelmans MA; Dorrius MD; van Ooijen PM; Wang Y; de Bock GH; Oudkerk M; Vliegenthart R
Radiology; 2014 Mar; 270(3):872-9. PubMed ID: 24475806
[TBL] [Abstract][Full Text] [Related]
75. Management of multiple pure ground-glass opacity lesions in patients with bronchioloalveolar carcinoma.
Kim HK; Choi YS; Kim J; Shim YM; Lee KS; Kim K
J Thorac Oncol; 2010 Feb; 5(2):206-10. PubMed ID: 19901852
[TBL] [Abstract][Full Text] [Related]
76. Computed tomography attenuation predicts the growth of pure ground-glass nodules.
Eguchi T; Kondo R; Kawakami S; Matsushita M; Yoshizawa A; Hara D; Matsuoka S; Takeda T; Miura K; Agatsuma H; Sakaizawa T; Tominaga Y; Saito G; Toishi M; Hamanaka K; Hashizume M; Shiina T; Amano J; Koizumi T; Yoshida K
Lung Cancer; 2014 Jun; 84(3):242-7. PubMed ID: 24681281
[TBL] [Abstract][Full Text] [Related]
77. Establishing and validation of the VBV score for assessing Lung ground-glass nodules based on high-resolution computed tomography.
Zhou Y; Cao X; Gu H; Gao S; Wu Y; Li H; Xiong B; Dong H; Lv Y; Yang R; Wu Y
J Cardiothorac Surg; 2024 Jan; 19(1):17. PubMed ID: 38263113
[TBL] [Abstract][Full Text] [Related]
78. Computed tomography quantitative analysis of components: a new method monitoring the growth of pulmonary nodule.
Linning E; Wu S; Wang K; Meng H; Sun D; Wu Z
Acta Radiol; 2013 Oct; 54(8):904-8. PubMed ID: 23761548
[TBL] [Abstract][Full Text] [Related]
79. Evaluation of the dual vascular supply patterns in ground-glass nodules with a dynamic volume computed tomography.
Wang C; Wu N; Zhang Z; Zhang LX; Yuan XD
World J Radiol; 2022 Jun; 14(6):155-164. PubMed ID: 35978977
[TBL] [Abstract][Full Text] [Related]
80. New horizons in surgical treatment of ground-glass nodules of the lung: experience and controversies.
Chen D; Dai C; Kadeer X; Mao R; Chen Y; Chen C
Ther Clin Risk Manag; 2018; 14():203-211. PubMed ID: 29430182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
